InsidersTradesSigma
同和药业 Stock: price and insider trades · China · SSE / SZSE (CSRC)
Track the 同和药业 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares are quoted on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 同和药业 has recorded 13 public disclosures. Market capitalisation: €3.2bn. The latest transaction was disclosed on 9 December 2021 (Purchase). Among the most active insiders: 庞正伟. The full history is accessible without an account.
13
Insider Decl.
0
Thresholds
·
13 ops.
Buy Volume
·
0 ops.
Sell Volume
36Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 17,350 of 26,212 companies
41.2
score / 100
Value37
Quality46
FCF yld-3.2%
Earn yld2.6%
EV/EBITDA15.7x
ROE3.0%
Gross mgn30%
Net mgn8.8%
Debt/EBITDA2.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 9 December 2021
Declarations13 total
13 of 13 declarations